Cerveau Technologies, Inc. and Enigma Biomedical Group, Inc., Sign Research Agreement with Centre for Addiction and Mental Health (CAMH), Toronto

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.